Mesenchymal Stem Cells Market 2023 | Industry Share and Forecast 2028
According to the latest report by IMARC Group, titled, “Mesenchymal Stem Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global mesenchymal stem cells market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the mesenchymal stem cells market?
The global mesenchymal stem cells market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.16 Billion by 2028, exhibiting a growth rate (CAGR) of 13.06% during 2023-2028.
What is mesenchymal stem cells?
Mesenchymal stem cells (MSCs) represent a type of adult stem cell that holds great promise in the field of regenerative medicine. They are present in several tissues in the body, such as bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp. MSCs possess the remarkable ability to differentiate into multiple types of cells, including bone cells, cartilage cells, muscle cells, and fat cells. They release numerous bioactive molecules, such as cytokines, and extracellular vesicles, which have important roles in tissue regeneration and repair. These molecules can stimulate nearby cells to divide and differentiate, promote the formation of new blood vessels, reduce scarring, and aid in tissue remodeling. Owing to their regenerative potential and their ability to modulate the immune system, MSCs are being extensively studied for an extensive range of therapeutic applications across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/mesenchymal-stem-cells-market/requestsample
What are the growth prospects and trends in the mesenchymal stem cells industry?
The mesenchymal stem cells market is primarily driven by the inflating healthcare expenditure and the growing prevalence of chronic diseases, especially among the geriatric population across countries. Additionally, the rising demand for effective therapies that can address the underlying causes of these health conditions is acting as another significant growth-inducing factor. In line with this, the elevating use of MSCs in promoting tissue repair and regeneration, making them a potential solution for various medical conditions, is also positively influencing the global market. Moreover, the escalating limitations and safety concerns associated with traditional treatment, the continuous improvements in healthcare infrastructure, and the expanding awareness among the population about the potential benefits of MSC-based therapies are expected to bolster the mesenchymal stem cells market in the coming years.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product & Services:
Products
Cells and Cell Lines
Kits, Media, and Reagents
Others
Services
Breakup by Type:
Autologous
Allogeneic
Breakup by Source of Isolation:
Bone Marrow
Cord Blood
Peripheral Blood
Fallopian Tube
Fetal Liver
Lung
Adipose Tissues
Breakup by Indication:
Bone and Cartilage Repair
Cardiovascular Disease
Inflammatory and Immunological Diseases
Liver Diseases
Cancer
GvHD
Others
Breakup by Application:
Disease Modelling
Drug Development and Discovery
Stem Cell Banking
Tissue Engineering
Toxicology Studies
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
ATCC
Axol Bioscience Ltd.
Cell Applications Inc.
Celprogen Inc.
Cyagen Biosciences Inc.
Lonza Group AG
Merck KGaA
PromoCell GmbH
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8062&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group